Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Marchex to Report Second Quarter 2008 Results on August 5 and MDC Partners schedules conference call to discuss its financial results for the second quarter and six months ended June 30, 2008
Jul 17, 2008 08:30 AM
- 2nd UPDATE: MDS 1Q Adjusted EPS Falls; Cuts Fiscal Year EPS View
Jun 05, 2008 11:02 AM
- UPDATE: MDS Inc. 1Q Adjusted EPS Falls; Cuts Fiscal Year EPS View
Jun 05, 2008 07:57 AM
- Earnings Summary: Wednesday, March 12, 2008
Mar 13, 2008 02:18 AM
- Earnings Summary: Tuesday, March 11, 2008
Mar 12, 2008 02:49 AM
- Earnings Reports
Mar 10, 2008 06:59 PM
- MDS Nordion In Supply Pact With Bradmer Pharmaceuticals
Apr 19, 2006 08:41 AM
- Applied Biosystems - Part of Life Technologies - Helps China Respond to Melamine Contamination in Dairy Products
Dec 02, 2008 12:59 AM
- MDS Inc. Announces Appointment of James S.A. MacDonald as Chairman of Board of Directors
Nov 19, 2008 07:01 AM
- MDS Inc. Announces Appointment of James S.A. MacDonald as Chairman of Board of Directors
Nov 19, 2008 07:00 AM
- Obrem Capital Management Issues Letter to MDS Management and Board of Directors
Oct 30, 2008 12:02 PM
- MDS Analytical Technologies Announces Availability of New High-Throughput Method to Detect Melamine in Food
Oct 30, 2008 08:02 AM
- MDS Analytical Technologies Announces Availability of New High-Throughput Method to Detect Melamine in Food
Oct 30, 2008 08:00 AM
- MDS Pharma Services Wins Two Good Clinical Practice Journal Awards
Oct 23, 2008 04:01 PM
- MDS Pharma Services Wins Two Good Clinical Practice Journal Awards
Oct 23, 2008 04:00 PM
- MDS Pharma Services Upgrades, Expands Singapore Global Central Laboratory Operation
Oct 16, 2008 08:03 AM
- MDS Pharma Services Upgrades, Expands Singapore Global Central Laboratory Operation
Oct 16, 2008 08:00 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
MDZ
|
Compare to S&P
|
| YTD |
-64.94 %
|
-0.01 %
|
| 4 Weeks |
-39.43 %
|
-28.23 %
|
| 12 Weeks |
-47.54 %
|
-24.32 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 0.00 %
|
|
EPS Growth in Last Year: -57.14 %
|
|
Sales Growth in Last Quarter: -8.29 %
|
|
Sales Growth in Last Quarter: 0.00 %
|
|
|
